Plain-English translation of NCT06386887 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether intermittent fasting—eating during an 8-hour window and fasting for 16 hours on certain days—can safely be done alongside platinum-based chemotherapy for ovarian cancer. Researchers believe that what you eat may affect how your body responds to cancer treatment, and they want to see if this eating pattern might help improve outcomes and reduce side effects.
Scientists have found that diet can influence how ovarian cancer develops and how well the body responds to chemotherapy. This study exists to learn whether this type of fasting might be a safe way to support your treatment and improve your quality of life during cancer care.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will either follow an intermittent fasting plan (fasting for 16 hours and eating during an 8-hour window, five days a week) or receive standard dietary recommendations. You'll keep food diaries at certain points during your chemotherapy cycles, and researchers will track how you feel, any side effects from chemotherapy, and changes in your body. The study involves about 20 participants total and will run alongside your regular cancer treatment.
AI-generated summary from trial data · Aug 18, 2026 · Not medical advice
United States